MSD Ireland creates new jobs in Carlow as they expand facilities with €1 billion investment

MSD Ireland announces official opening of new facilities in Carlow.

MSD Ireland is one of the country’s leading healthcare companies.

The company announced a significant expansion at its Carlow site today alongside the official opening of a new, state-of-the-art site in Meath.

The projects represent a recent investment of over €1 billion across both facilities.

MSD Carlow was established in 2008, and was the companies first vaccines operation outside of the United States. MSD Carlow has seen significant growth, expansion, and investment since first opening its doors over fifteen years ago.

The new expansion to the state-of-the-art facility will strengthen MSD’s global manufacturing capabilities to meet increased demand for MSD’s medicines and vaccines and create further jobs in Carlow.

Speaking about the announcement, Taoiseach Leo Varadkar TD said: “This is fantastic news for counties Meath and Carlow with the opening by MSD of its new state of the art facility in Meath and the expansion of its Carlow site. The €1 billion investment by MSD is creating 670 jobs and expanding the company’s operations. It reinforces the Government’s commitment to balanced regional development, and further enhances Ireland’s global status in the pharmaceutical sector.”

Marie Martin, Site Lead at MSD Carlow, said: “Today’s announcement is a testament to the talent, hard work, and commitment of our team in Carlow and our colleagues across Ireland and internationally, who truly take our mission to Invent for Life to the next level every single day. Over the past 15 years, we are proud to have built a world-class centre of excellence for MSD in Carlow. We’re proud to be making our mark when it comes to positioning Ireland as a world-leader in pharmaceuticals, driving invention and innovation forward from Carlow to the world.”